Drug-induced liver injury associated with lopinavir-ritonavir in patients with COVID-19: a disproportionality analysis of U.S. food and drug administration adverse event reporting system (FAERS) data

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology

(2020) Eva Schrezenmeier et al.   Nature Reviews Rheumatology

COVID-19: Abnormal liver function tests

(2020) Qingxian Cai et al.   JOURNAL OF HEPATOLOGY

A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

(2020) Bin Cao et al.   NEW ENGLAND JOURNAL OF MEDICINE

Liver injury in COVID-19: management and challenges

(2020) Chao Zhang et al.   Lancet Gastroenterology & Hepatology

Clinical Features of COVID-19-Related Liver Functional Abnormality

(2020) Zhenyu Fan et al.   Clinical Gastroenterology and Hepatology

Drug-Induced Liver Injury and COVID-19 Infection: The Rules Remain the Same

(2020) Alexandre Olry et al.   DRUG SAFETY

Lopinavir-Ritonavir in the Treatment of COVID-19: A Dynamic Systematic Benefit-Risk Assessment

(2020) Vicki Osborne et al.   DRUG SAFETY

A living WHO guideline on drugs for covid-19

(2020) François Lamontagne et al.   BMJ-British Medical Journal

Drug-Induced Liver Injury Associated With Antidepressive Psychopharmacotherapy: An Explorative Assessment Based on Quantitative Signal Detection Using Different MedDRA Terms

(2015) Maximilian Gahr et al.   JOURNAL OF CLINICAL PHARMACOLOGY